How to Become a Medical Marijuana Patient in Poland? Guide 2026

Guides about medical marijuana in Poland repeat several numbers that cannot be verified and omit regulations that actually determine the course of therapy. This text does the opposite. Every term, limit, and sanction below comes from a specific editorial unit of the applicable act, verified in the Journal of Laws register, not from approximations repeated online. Here you will find answers to why the first prescription requires a personal visit, how many days of use one prescription can cover, exactly what penalties apply for driving a car, and what document you need when crossing the border. Separately, we show which popular numbers we removed from this guide and why none of them could be traced to a source. The order of sections corresponds to the order in which these matters appear in a patient’s life, from the first visit to traveling abroad. The legal status is described as of August 10, 2026.

KEY INFORMATION
• A prescription for cannabis herb other than fiber hemp is issued after a personal examination of the patient; exceptions apply to treatment continuation and situations where no more than 3 months have passed since the last examination.
• The prescription fulfillment period for narcotic drugs is 30 days from the date of issue, compared to 365 days for a regular e-prescription.
• One prescription can cover an amount corresponding to a maximum of 90 days of use.
• The law does not provide an exception for patients behind the wheel: art. 178a § 1 of the Penal Code provides imprisonment of up to 3 years.
• The value of 1 ng/ml THC in blood is the detection limit of the method, not a threshold of responsibility.

What is the legal basis for medical marijuana in Poland?

It is based on one provision of the Act on Counteracting Drug Addiction. Article 33a states that cannabis herb other than fiber hemp and extracts, pharmaceutical tinctures, and other extracts from this cannabis may constitute a pharmaceutical raw material intended for the preparation of magistral drugs, after obtaining a marketing authorization issued by the President of the Office for Registration of Medicinal Products.

This distinction changes the way the entire therapy is viewed. Dried herb from the pharmacy is not a ready-made medicine with a leaflet and registration indications but a raw material for a magistral drug. The authorization for a given raw material is issued for five years, and the responsibility for selecting the strain, dose, and route of administration lies with the prescribing doctor. This explains the variability in practice between clinics: the regulation does not impose a protocol but only permits the raw material to be marketed.

The basis was introduced by the Act of July 7, 2017, amending the Act on Counteracting Drug Addiction, which came into force on November 1, 2017. The current consolidated text of the Act on Counteracting Drug Addiction is Journal of Laws 2023 item 1939. The amendment of July 3, 2026, effective August 27, 2026, does not change anything regarding patient access to the raw material or prescription rules. Step by step, the procedure for obtaining a prescription is described in a separate guide to the prescription obtaining process.

For which indications is the evidence strongest?

For chronic pain and spasticity, and even there we speak of moderate quality evidence. A systematic review covering 79 randomized studies and 6462 participants found moderate quality evidence for cannabinoids in chronic pain and spasticity, and low quality evidence for nausea and vomiting after chemotherapy, weight gain in HIV infection, sleep disorders, and Tourette’s syndrome (Whiting et al., 2015).

A newer review broke down the picture by cannabinoid type, which is practically important for patients because dried herb, dronabinol, and oromucosal spray are not the same substance. The authors analyzed 152 randomized studies involving 12,123 people and obtained 84 comparisons (Bilbao and Spanagel, 2022).

The authors’ conclusions are cautious: cannabinoids are effective in several indications if their different pharmacology is considered. Post-traumatic stress disorder, ADHD, depression, and anxiety fall into the category of low or no evidence, which does not mean a doctor cannot propose therapy, only that there is no basis to promise effectiveness.

Can a prescription be obtained via teleconsultation?

Usually not the first one. The Minister of Health’s regulation on narcotic drugs requires that a prescription for products listed in Annex 2 be issued after a prior personal examination of the patient by the prescribing person. In this annex, alongside fentanyl, morphine, and oxycodone, there is an entry covering cannabis herb other than fiber hemp and pharmaceutical extracts and tinctures, and separately cannabis resin.

This is the most often overlooked element of the entire path and determines the choice of clinic. The provision is in paragraph 7 section 2a point 2 of the Minister of Health’s regulation of September 11, 2006, consolidated text Journal of Laws 2025 item 1678. The same section requires prior checking in the system or collecting an interview whether the products previously prescribed to the patient are sufficient for pharmacotherapy.

There are two exceptions. A prescription without examination, in the mode provided for teleconsultation, can be issued if no more than 3 months have passed since the last patient examination. Separately exempt is a doctor providing services under a primary health care contract, outside night and holiday health care, when continuing treatment started earlier with the same preparation.

The practical conclusion is that the “everything remotely from the first contact” model does not fit these regulations for cannabis herb. The first visit must be in person, and only subsequent ones can be remote, provided they fall within the three-month window from the last examination. When planning therapy, it is worth scheduling visits so that this window does not close.

What to prepare before the first visit?

Two things weigh the most: documented history of previous treatment and a complete list of medications taken. The first is needed because the regulation requires the doctor to establish that previous pharmacotherapy is insufficient. The second because cannabinoids actually alter the metabolism of other substances, and the doctor cannot predict this without a complete list.

It is worth bringing hospital discharge summaries, imaging study reports, laboratory results from the last six months, and a symptom diary kept for two to four weeks. The diary does not have to be complicated: time, symptom intensity on a scale from 0 to 10, sleep duration, and what worsened the symptom. Such a record gives the doctor a reference point that a single conversation cannot replace.

The medication list has measurable importance. Cannabidiol affects enzymes involved in the metabolism of many drugs and P-glycoprotein responsible for their excretion, and nearly half of people taking it in studies reported dose-dependent adverse effects (Brown and Winterstein, 2019). A meta-analysis of twelve studies involving 803 people shows where the real risk lies: abnormal liver tests and drowsiness occurred mainly in studies on childhood epilepsy where cannabidiol was given with clobazam or valproate, and after their exclusion, the only significant complication remaining was diarrhea (Chesney et al., 2020).

Which drugs may interact with cannabis therapy?

Those metabolized by liver cytochrome P450 enzymes, and the list is longer than usually stated. Studies on microsomes of cells overexpressing individual enzymes showed that each main cannabinoid competitively inhibits a different set, so the interaction profile depends on the strain composition, not just on the fact of cannabis use.

More interesting is what metabolites do. In the plasma of cannabis users, they persist longer and at higher concentrations than cannabinoids themselves, and the two main THC metabolites inhibited the above enzymes at concentrations lower than the parent compounds. The authors point out that circulating metabolites may be responsible for a significant part of interactions, which is usually not considered when planning therapy (Nasrin et al., 2021).

Practically, this means one thing: before the first prescription, the doctor should see a full list of medications, including over-the-counter drugs and supplements. Enzymes from this family metabolize, among others, anticoagulants and antiepileptics, as well as a significant portion of psychiatric drugs, so changes in their activity translate into the concentration of drugs the patient already takes. This is not a reason not to start therapy but to start it with a full record.

Separately, it is worth knowing the state of knowledge about absorption. A systematic review of cannabidiol pharmacokinetics in humans established that absolute bioavailability was measured only for the inhalation route, where it was 31 percent; for no other route was it attempted despite the availability of intravenous forms. The authors emphasize the scarcity of data and discrepancies between studies (Millar et al., 2018). Dose conversion between vaporization and oral administration thus lacks a solid numerical basis.

How much time do you have to fill an Rpw prescription?

Thirty days from the date of issue. The deadline results from Article 96a paragraph 7 point 4 of the Pharmaceutical Law, which sets this period for prescriptions for narcotic drugs, psychotropic substances, and category 1 precursors. For comparison, a regular electronic prescription has a fulfillment period of 365 days, and an antibiotic prescription 7 days.

The second limit concerns quantity and is often confused with the first. A prescription for preparations containing narcotic substances of group I-N may cover an amount not exceeding the patient’s need for a maximum of 90 days of use, and the doctor may issue up to three prescriptions for consecutive periods, also totaling up to 90 days. Thirty days is the window to purchase the medicine; ninety is the maximum supply a prescription can cover.

Technically, the electronic prescription generates two numbers: a 44-digit access key and a 4-digit code. At the pharmacy, it is enough to provide the code together with the PESEL number, and this is the same procedure you know from any other e-prescription. The current consolidated text of the Pharmaceutical Law is Journal of Laws 2026 item 612.

How to find a pharmacy that really has the product?

By phone, before leaving home. Cannabis herb is dispensed as a pharmaceutical raw material for magistral drugs, not as a ready-made product from the general shelf, so the pharmacy must have both the appropriate permit and the specific strain physically in stock. These two conditions are independent, and the second is often more problematic than the first.

When calling, provide the full name of the strain and the gram amount from the prescription, not just the keyword “medical marijuana.” Strains differ in THC and CBD content, and the pharmacy will not substitute one for another without a new prescription because it is a different raw material. Also ask about the possibility of reservation: many pharmacies hold orders for a day or two, which can be important if the trip takes half a day.

If your strain is not available, you have two options. The first is to order and wait for delivery, but remember the 30-day prescription fulfillment period, which runs independently of whether the pharmacy has the product. The second is to contact the doctor and get a new prescription for an available strain with a similar profile. The second is often faster but requires a visit or teleconsultation within the three-month window from the last examination. We track which strains are currently on the market in the list of available strains.

How does therapy start and dose titration proceed?

It starts with small doses and increases slowly over a week or two. A practical pharmacology guide for medical cannabis recommends starting at modest levels and titrating over up to two weeks, usually limiting the total daily THC dose to 30 mg or less, preferably together with cannabidiol to avoid psychoactive effects and tolerance development (MacCallum and Russo, 2018).

Specific numbers come from a consensus of twenty experts from nine countries, developed by the Delphi method for chronic pain. In the basic protocol, treatment starts with a strain high in cannabidiol at 5 mg twice daily, increased by 10 mg every two to three days up to 40 mg per day. Only at this level is THC added at 2.5 mg and increased by 2.5 mg every two to seven days. The cautious protocol starts THC at 1 mg per day and increases by 1 mg every seven days (Bhaskar et al., 2021).

The third variant from this consensus is often omitted but may be closest to Polish practice. In the rapid protocol, treatment starts immediately with a balanced strain, 2.5 to 5 mg of each cannabinoid once or twice daily, increasing by the same amount every two to three days. The upper THC limit is the same in all three variants and is 40 mg per day. This is higher than the 30 mg suggested in the practical guide cited above, and this discrepancy itself says something about the state of knowledge: two independent expert sets give upper limits differing by one third for the same substance.

Take the first dose in the evening, on a day without planned driving or obligations. Record the time of intake, dose, form, symptom intensity before administration, and after one, two, and four hours. These records are the only objective basis on which the doctor will assess during a follow-up visit whether the dose needs adjustment. If therapy is to be via vaporization, choose the device before the first dose; we collected a review of devices in the vaporizers category.

Why can’t a patient with a prescription drive a car?

Because neither the Penal Code nor the Code of Petty Offenses provides an exception for a person using a narcotic substance on prescription. Article 178a paragraph 1 of the Penal Code states that anyone who drives a motor vehicle under the influence of a narcotic substance is subject to imprisonment of up to 3 years. Upon conviction, the court also imposes a financial penalty of at least 5000 PLN.

A milder state is described by Article 87 paragraph 1 of the Code of Petty Offenses: driving a motor vehicle after using a substance acting similarly to alcohol is punishable by arrest or a fine of not less than 2500 PLN, and the court then imposes a driving ban. The distinction between “under the influence” and “after use” determines whether the case proceeds as a crime or a petty offense.

There is also the number 1 ng/ml sometimes given as a threshold of responsibility. This is a misunderstanding. This value comes from paragraph 3 of the Minister of Health’s regulation of July 16, 2014, and represents the detection limit of the method for delta-9-THC in blood; for urine, the regulation specifies 20 ng/ml for the metabolite 11-nor-9-carboxy-THC. The act contains no threshold for saliva (Journal of Laws 2014 item 948).

Regarding actual driving ability, a study with driving on a public road showed that after vaporization of THC-dominant cannabis and balanced cannabis, lane-keeping ability was significantly impaired between 40 and 100 minutes after administration, and between 240 and 300 minutes the difference from placebo was no longer significant (Arkell et al., 2020). What documents to carry during a check are detailed in the text about police checks and medical marijuana.

What about workplace tests and traveling abroad?

Urine tests do not measure what most people think they measure. In a study conducted in a closed ward under 24-hour medical supervision, THC was detected in urine of some chronic cannabis users even after several days, and in one case after 24 days of abstinence. The authors explicitly state that these results exclude the use of these compounds as indicators of recent intake (Lowe et al., 2009).

This has double significance for the patient. A positive test result does not prove that you took a dose today or that you are under the influence, but it does not exempt you from consequences because many workplace regulations count the mere presence of the substance. Talking to the occupational medicine doctor and showing the prescription before periodic testing solves more problems than explaining afterward.

Who to inform and who not is decided by law, not courage. The occupational medicine doctor is a medical professional bound by confidentiality described later in this text, so information given to them does not automatically reach the employer. The HR department or direct supervisor are not listed in the exceptions to this confidentiality, so unless disclosure is required by other laws, the decision to inform them belongs to the patient. If the industry requires control tests, it is more sensible to agree with the occupational medicine doctor on how to describe therapy in the certificate than to hope the topic will not come up.

When traveling, the procedure described in the Minister of Health’s regulation of June 8, 2026 applies. When traveling to an EU country, the document is issued by the relevant provincial pharmaceutical inspector, according to instructions in the Executive Committee decision of December 22, 1994, regarding the certificate provided for in Article 75 for transporting narcotic drugs. When importing or exporting outside the EU, the document is issued by the Chief Pharmaceutical Inspector upon the applicant’s request, with the prescription or medical documentation attached.

Two deadlines are identical in both cases and determine trip planning: the document is issued for no longer than 30 days, and the application must be submitted no later than 15 days before crossing the border. The document issued by the Chief Pharmaceutical Inspector is printed on pink paper with security features provided for public documents of category three.

What rights does a patient have if a doctor refuses?

The patient has the right to request a second opinion but not to enforce it. Article 6 paragraph 3 point 1 of the Patient Rights Act gives the patient the right to demand that the attending doctor seek the opinion of another doctor or convene a medical council. Paragraph 4 of the same article allows the doctor to refuse if they consider the demand unjustified.

The key is paragraph 5: both the patient’s demand and the doctor’s refusal must be recorded in the medical documentation. This is a real tool because the record remains and can be cited in proceedings before the patient rights commissioner or the medical chamber. Asking to have the refusal entered into the documentation costs one sentence and changes the nature of the conversation.

Confidentiality is separately protected. Article 13 of the Act grants the patient the right to keep information obtained in connection with the medical profession confidential, and Article 14 imposes a corresponding obligation on medical professionals and lists a closed catalog of exceptions. The employer and insurer are not in this catalog. The consolidated text of the Act is Journal of Laws 2024 item 581.

How to plan the budget and therapy continuity?

Start with a calendar, not an amount. Three deadlines set the rhythm of the entire therapy: 30 days to fill the prescription, up to 90 days of use covered by one prescription, and 3 months from the last personal examination after which teleconsultation is no longer sufficient to issue another. Together, they mean that an in-person visit must return at least quarterly, and medicine purchase cannot wait.

We do not provide specific prices per gram, and this is a conscious decision. Raw material prices are set by pharmacies, vary between strains and suppliers, and every number we found in Polish guides led to a source that could not be opened or verified. Providing such a figure here would mean copying someone else’s unverified number, which is worse than none in a patient’s budget.

What can be said without guessing: the cannabis herb as raw material for magistral drugs is paid for by the patient, and to the cost of the raw material itself add visits and a one-time expense for administration equipment if therapy is based on vaporization. You can find the current price of a specific strain most quickly by the same phone call to the pharmacy where you check availability, and that is the only source true on the day of purchase.

Which numbers will you not find in this text and why?

You will not find the percentage of Polish doctors issuing Rpw prescriptions, the number of pharmacies with permits, the tonnage of herb sold in a given year, or the percentage of patients hiding therapy from their employer. All these numbers circulate in Polish guides; we checked them individually and could not trace any to a source the reader could open and verify.

The pattern was always the same. A sentence with a specific number and institution name, and under the link the homepage or a general information subpage where the number is not present. The link matches, the response code is correct, so at a glance everything looks verified. Only opening the page shows it does not lead to any report.

We noticed that the most dangerous are probable numbers. Claims of a few percent of doctors or one and a half thousand pharmacies sound credible and are not questioned, yet no one can point to a measurement. In a guide on which the reader plans treatment and expenses, such a number is worse than none because it looks like knowledge.

We did check what could be checked at the source: every term, limit, and sanction in this text comes from the consolidated text of the act read in the Journal of Laws register, and every claim about efficacy or safety from a work whose abstract we opened and compared with the supporting sentence. Where there was nothing to check, there is no sentence.

What to remember from this path?

That most problems come not from pharmacology but from deadlines. The first prescription requires a personal examination because cannabis herb other than fiber hemp is listed in the annex requiring this. Subsequent prescriptions can be remote but only within three months of the last examination. Prescription fulfillment is 30 days, and one prescription covers at most 90 days of use.

That the evidence base is narrower than popular narrative suggests. Moderate quality evidence concerns chronic pain and spasticity, high only cannabidiol in epilepsy. The rest of the indications fall into low or no evidence categories, so the conversation with the doctor should concern probability, not promise.

And that a prescription does not protect behind the wheel. The law distinguishes “under the influence,” punishable by up to 3 years imprisonment, and “after use,” punishable by arrest or a fine of not less than 2500 PLN. The value 1 ng/ml sometimes given as a threshold is the detection limit of the laboratory method. Planning transport without your own car is part of therapy, not an addition to it.

Sources

We verified legal acts in the Journal of Laws register: for each, we read the consolidated text and status of validity, not just the page response code. Scientific works were checked in the Europe PMC database by opening the abstract and comparing it with the supporting sentence.

1. Act on Counteracting Drug Addiction, consolidated text Journal of Laws 2023 item 1939 - art. 33a, pharmaceutical raw material for magistral drugs.
2. Act of July 7, 2017, Journal of Laws 2017 item 1458 - effective November 1, 2017.
3. Pharmaceutical Law, consolidated text Journal of Laws 2026 item 612 - art. 96a para. 7 point 4, fulfillment period 30 days.
4. Minister of Health regulation of September 11, 2006, consolidated text Journal of Laws 2025 item 1678 - § 6 para. 2, § 7 paras. 1, 2, 2a, 2b, and 2d and Annex 2.
5. Minister of Health regulation of July 16, 2014, Journal of Laws 2014 item 948 - detection limits for blood and urine.
6. Minister of Health regulation of June 8, 2026, Journal of Laws 2026 item 827 - § 5 and § 6, documents for border crossing.
7. Patient Rights Act, consolidated text Journal of Laws 2024 item 581 - art. 6 paras. 3-5 and art. 13 and 14.
8. Whiting P.F. et al., 2015 - review of 79 randomized studies and 6462 participants.
9. Bilbao A. and Spanagel R., 2022 - 152 randomized studies by cannabinoid type.
10. Bhaskar A. et al., 2021 - Delphi consensus on dosing in chronic pain.
11. Arkell T.R. et al., 2020 - study of driving ability after vaporization.
12. Lowe R.H. et al., 2009 - prolonged THC excretion in urine in chronic users.

Frequently Asked Questions

Can I get the first prescription for medical marijuana remotely?

Usually not. The Minister of Health’s regulation requires a personal examination of the patient before issuing a prescription for products listed in Annex 2, which includes cannabis herb other than fiber hemp. A prescription without examination can be issued if no more than 3 months have passed since the last patient examination.

How many days is an Rpw prescription valid?

The fulfillment period is 30 days from the date of issue or from the indicated “from date”. This results from Article 96a paragraph 7 point 4 of the Pharmaceutical Law, which covers narcotic drugs, psychotropic substances, and category 1 precursors. For comparison, a regular e-prescription has a validity of 365 days.

For how many days of therapy can one prescription be issued?

For a maximum of 90 days of use. The doctor can also issue up to three prescriptions for consecutive periods, whose total also does not exceed 90 days of use. Additionally, only one preparation containing a narcotic substance can be prescribed on one prescription, and no other medicines may be included.

Can a patient with a prescription drive a car?

There is no exception for them. Article 178a paragraph 1 of the Penal Code provides for imprisonment of up to 3 years and a financial penalty of at least 5000 PLN for driving under the influence of a narcotic substance. The state after use is subject to Article 87 paragraph 1 of the Code of Petty Offenses: arrest or a fine of not less than 2500 PLN.

Is 1 ng/ml THC in blood the threshold of responsibility?

No. It is the detection limit of the laboratory method for delta-9-THC in blood, specified in the Minister of Health’s regulation of July 16, 2014. For urine, the regulation specifies 20 ng/ml for the metabolite 11-nor-9-carboxy-THC. The act does not contain any threshold for saliva, although such a number circulates in guides.

How long does THC remain in urine?

Longer than the colloquial “a few days” suggests. In a study conducted under supervised abstinence in chronic users, THC was detected in urine from 3 to 24 days after cessation. The authors conclude that the result of such a test is not an indicator of recent substance intake and says nothing about current impairment.

What documents are needed when crossing the border?

When traveling to an EU country, the document is issued by the provincial pharmaceutical inspector; outside the EU, by the Chief Pharmaceutical Inspector. In both cases, the document is issued for no longer than 30 days, and the application must be submitted no later than 15 days before crossing the border of the Republic of Poland.

Does medical marijuana cause addiction?

The risk exists but is lower than with nicotine or alcohol. In an analysis of a US population study, the cumulative probability of transitioning from use to addiction was 8.9 percent for cannabis, compared to 22.7 percent for alcohol and 67.5 percent for nicotine (Lopez-Quintero et al., 2011).

This article is for informational and educational purposes and does not constitute legal advice. The legal status described in the article is valid on the publication date: cannabis regulations may change. Consult a lawyer or current legal acts before making decisions.

Author: Michał Waluk · Published: 2026-05-11 · Updated: 2026-08-10